NPT189

DRUG2 trials

Sponsors

Proclara Biosciences, Inc.

Conditions

Amyloidosis

Phase 1

A Study of NPT189 in Healthy Subjects

CompletedNCT03610035

Proclara Biosciences, Inc.Amyloidosis

Start: 2018-07-24End: 2019-02-17Updated: 2019-08-15

Multiple Ascending Dose Study in Healthy Subjects

TerminatedNCT03879278

Proclara Biosciences, Inc.Amyloidosis

Start: 2019-03-06End: 2019-06-27Updated: 2019-08-19